View Item 

Show simple item record

Do guidelines preclude hepatitis B patients from receiving treatment? Potential conflict of interest: Dr. Lok is a consultant for and received grants from Gilead and Schering-Plough. She is also a consultant for Roche and received grants from Bristol-Myers Squibb, GlaxoSmithKline, and Novartis.

dc.contributor.authorDegertekin, Bulenten_US
dc.contributor.authorLok, Anna Suk-Fongen_US
dc.date.accessioned2009-03-03T20:11:32Z
dc.date.available2010-04-14T17:40:06Zen_US
dc.date.issued2009-02en_US
dc.identifier.citationDegertekin, Bulent; Lok, Anna S.; Degertekin, Bulent; Lok, Anna S. (2009). "Do guidelines preclude hepatitis B patients from receiving treatment? Potential conflict of interest: Dr. Lok is a consultant for and received grants from Gilead and Schering-Plough. She is also a consultant for Roche and received grants from Bristol-Myers Squibb, GlaxoSmithKline, and Novartis. ." Hepatology 49(2): 700-701. <http://hdl.handle.net/2027.42/61902>en_US
dc.identifier.issn0270-9139en_US
dc.identifier.issn1527-3350en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/61902
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=19177583&dopt=citationen_US
dc.description.abstractNo abstract.en_US
dc.format.extent64176 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherWiley Subscription Services, Inc., A Wiley Companyen_US
dc.subject.otherLife and Medical Sciencesen_US
dc.subject.otherHepatologyen_US
dc.titleDo guidelines preclude hepatitis B patients from receiving treatment? Potential conflict of interest: Dr. Lok is a consultant for and received grants from Gilead and Schering-Plough. She is also a consultant for Roche and received grants from Bristol-Myers Squibb, GlaxoSmithKline, and Novartis.en_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDivision of Gastroenterology, University of Michigan Medical Center, Ann Arbor, MIen_US
dc.contributor.affiliationumDivision of Gastroenterology, University of Michigan Medical Center, Ann Arbor, MIen_US
dc.identifier.pmid19177583en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/61902/1/22722_ftp.pdf
dc.identifier.doi10.1002/hep.22722en_US
dc.identifier.sourceHepatologyen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
22722_ftp.pdf
Size:
62.67KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.